Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous System
- Status
- COMPLETED
- Phase
- PHASE4
Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE2
Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1
A Trial of One-week on/One-week Off Temozolomide Versus Continuous Dose-Intense Temozolomide in Patients With Glioblastoma Multiforme at First Relapse
- Status
- COMPLETED
- Phase
- PHASE2
Image-derived Prediction of Response to Chemo-radiation in Glioblastoma
- Status
- TERMINATED
- Phase
- N/A
A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
- Status
- COMPLETED
- Phase
- PHASE1
Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children
- Status
- COMPLETED
- Phase
- PHASE2
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Efficacy and Tolerability of Cisplatin Plus Alternating Weekly Temozolomide in Recurrent High-grade Gliomas
- Status
- COMPLETED
- Phase
- PHASE2
Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1
Temozolomide 12 Cycles Versus 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma.
- Status
- COMPLETED
- Phase
- PHASE2
A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas
- Status
- UNKNOWN
- Phase
- PHASE2
IDH1 Peptide Vaccine for Recurrent Grade II Glioma
- Status
- COMPLETED
- Phase
- PHASE1
Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma
- Status
- TERMINATED
- Phase
- PHASE1
Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2